Costa Rica vs United Kingdom: Prevalence of anemia among women of reproductive age
Costa Rica
13.7%
in 2023
United Kingdom
13.6%
in 2023
Costa Rica rank
184th
United Kingdom rank
185th
Prevalence of anemia among women of reproductive age over time
- Costa Rica
- United Kingdom
How they compare
Costa Rica currently reports 13.7% against 13.6% in United Kingdom, a difference of 0.1%.
The two have swapped places 2 times across 24 shared years of data; in 2000 it was Costa Rica ahead.
Costa Rica ranks 184th and United Kingdom ranks 185th of 192 countries.
Across the 3 decades both report, Costa Rica averaged higher in 1 and United Kingdom in 2.
Head to head by decade
| Decade | Costa Rica | United Kingdom | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.9% | 9.6% | 3.4% | Costa Rica |
| 2010s | 10.6% | 11.1% | 0.4% | United Kingdom |
| 2020s | 12.8% | 12.9% | 0.2% | United Kingdom |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of anemia among women of reproductive age, Costa Rica or United Kingdom?
- Costa Rica, at 13.7% against 13.6% in United Kingdom as of 2023.
- What is the difference in prevalence of anemia among women of reproductive age between Costa Rica and United Kingdom?
- 0.1%, with Costa Rica ahead.
- How many years of comparable data are there for Costa Rica and United Kingdom?
- 24 years are reported by both, from 2000 to 2023.
- How do Costa Rica and United Kingdom rank globally for prevalence of anemia among women of reproductive age?
- Costa Rica ranks 184th and United Kingdom ranks 185th of 192 countries.
- Where does this data come from?
- Global Health Observatory Data Repository/World Health Statistics, World Health Organization (WHO), published as Prevalence of anemia among women of reproductive age (% of women ages 15-49). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of anemia among women of reproductive age refers to the combined prevalence of both non-pregnant with haemoglobin levels below 12 g/dL and pregnant women with haemoglobin levels below 11 g/dL.